PFSA
Profusa, Inc. Common Stock · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-04-15
Figures on this page computed 2026-11-08 12:40 UTC
Last close
0.62USD
Market data, 2026-11-04
Except where said otherwise: 10-K for 2025, filed 2026-04-15
n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001213900-26-044046
- Reported in
- USD
- computed
- 10-K for 2025, filed 2026-04-15
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001213900-26-044046
- Reported in
- USD
- 10-K for 2025, filed 2026-04-15
- 10-K for 2025, filed 2026-04-15
- 10-K for 2025, filed 2026-04-15
- 10-Q for 2025, filed 2026-08-19
- 10-K for 2025, filed 2026-04-15
- 10-Q for 2025, filed 2026-05-15
n/aNet margin
We do not hold this figure for this company, so there is nothing to place.
Net Income / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001213900-26-044046
- Reported in
- USD
- 10-K for 2025, filed 2026-04-15
- 10-K for 2025, filed 2026-04-15
n/aFCF margin
We do not hold this figure for this company, so there is nothing to place.
Free Cash Flow / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001213900-26-044046
- Reported in
- USD
- 10-K for 2025, filed 2026-04-15
- 10-K for 2025, filed 2026-04-15
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001213900-26-044046
- Reported in
- USD
- 10-K for 2025, filed 2026-04-15
- 10-Q for 2025, filed 2026-08-19
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
Safety is the furthest below its sector's middle: 0.02 against 0.72 on the market's range.
- Growth-288.1%8 of 100, below its sector
- Returns on capital-949.0%0 of 100, below its sector
- Marginsn/anot placed
- Pricen/anot placed
- Safety0.172 of 100, below its sector
- What it pays outn/anot placed
- Margins: n/aWe do not hold this figure for this company, so there is nothing to place.
- Price: n/aWe do not hold this figure for this company, so there is nothing to place.
- What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.
Five bars, one line
lens 7 of 9Each against its own average
3 of 5 readExcept where said otherwise: 10-K for 2025, filed 2026-04-15
- Salesn/a
Its own average over 1 year, 100.0K.
- Profit3.81x
Its own average over 5 years, -9.4M.
- Free cash flow1.21x
Its own average over 2 years, -13.5M.
- Debtn/a
Its own average over 2 years, 12.1M.
- Price0.00x
Its own average over 2 years, 1.2K. Market data, 2026-11-04
Profit is furthest from its own average, at 3.81 times.
Profit is 3.81 times its own 5-year average; Free cash flow is 1.21 times its own 2-year average; Price is 0.00 times its own 2-year average.
Every figure in this lens
Except where said otherwise: 10-K for 2025, filed 2026-04-15
Sales against its own 1-year averagen/a
Not held.
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001213900-26-044046
- Reported in
- USD
Profit against its own 5-year average3.81
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001213900-26-044046
- Reported in
- USD
Free cash flow against its own 2-year average1.21
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001213900-26-044046
- Reported in
- USD
Debt against its own 2-year averagen/a
Not held.
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001213900-26-044046
- Reported in
- USD
Price against its own 2-year average0.001Market data, 2026-11-04
- Source
- market
- Taken on
- 2026-11-04
- Reported in
- USD